Research at Uppsala Antibiotic Center
Uppsala Antibiotic Center started funding 14 PhD projects in 2017 and 14 additional ones in 2021, all relating to antibiotics and the curbing of antimicrobial resistance. From 2025, doctoral students and other researchers in Uppsala have also joined the center, expanding the research expertise hosted at UAC. These projects are located at the three disciplinary domains at Uppsala University (UU) and at the Swedish University of Agricultural Sciences (SLU). Here you can explore all of them by area and project topic.
Research Projects
- AMR Drivers & Policy Action
- AMR dynamics in livestock
- AMR in Aquatic Environments
- AMR in Small-Scale Poultry Farming in Vietnam
- Access to Diagnostics
- Antibiotic Discovery with Small Molecules
- Antibiotic Prescriptions
- Antibiotic Resistance by Target Binding
- Antibiotic Usage in LMICs
- Antibiotic effects from novel in-vitro modelling
- Antibiotics and Diabetes Type I
- Bacterial Persisters
- Barriers to Diagnostics Uptake
- Biofilms & Klebsiella
- Chemokines' antimicrobial effect
- Chromosomal Hybrids & Resistance
- Colistin PK-PD
- Combination Therapy
- Consumer Behaviour and AMR
- DNA-encoded libraries for LpxH inhibitors
- Delivery & Absorption of Antibiotics
- Diagnostics with Nanoparticles
- Effect of Antibiotics in Infected Tissue
- HGT & Resistance
- Heteroresistance & ASTs
- Heteroresistance by gene dosage
- Heteroresistance evolution
- Metallo-beta-lactamases Inhibitors
- Metronidazole Resistance
- Microfluidics AST
- Multi-sectorial Partnerships for Antibiotic Development
- New Antibiotic R&D Models
- New Treatments Against C. diff
- Novel Antifungal Targets in Candida
- Novel Lep-B Inhibitors
- PBPK and PKPD Modeling for Pulmonary Drug Delivery
- Pharmaceuticals in the environment
- Plasmid copy number dynamics
- Ribosome Tracking to Study Treatment
- Swedish Antibiotic Stewardship
- Swedish Antibiotics Research
- Targeted Eradication of Bacteria
- Targeted protein degradation for antibacterial discovery
- Time-lapse microscopy for PKPD modeling
- Toxin–Antitoxin Systems and Antibiotic Persistence
- Treatment of difficult infections
- Type I Toxin-Antitoxin Systems
- Zoonotic Campylobacter and AMR